Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
1990-3-14
|
| pubmed:abstractText |
Ofloxacin was administered to 26 males infected with Ureaplasma urealyticum. The infection was confirmed by urine or semen culture. Ofloxacin, administered at daily dose of 300-600 mg for 7 to 28 days, eradicated U. urealyticum in 25 of 26 patients (92.2%).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0018-1994
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2149-53
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading | |
| pubmed:year |
1989
|
| pubmed:articleTitle |
Effect of ofloxacin in the treatment of genitourinary tract infection with Ureaplasma urealyticum.
|
| pubmed:affiliation |
Department of Urology, School of Medicine, Tokai University.
|
| pubmed:publicationType |
Journal Article
|